Avadel Pharmaceuticals (AVDL) Long-Term Debt Repayments (2016 - 2018)
Historic Long-Term Debt Repayments for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Q3 2018 value amounting to $430000.0.
- Avadel Pharmaceuticals' Long-Term Debt Repayments changed N/A to $430000.0 in Q3 2018 from the same period last year, while for Sep 2019 it was $430000.0, marking a year-over-year decrease of 9305.33%. This contributed to the annual value of $161000.0 for FY2014, which is 10909.09% up from last year.
- As of Q3 2018, Avadel Pharmaceuticals' Long-Term Debt Repayments stood at $430000.0.
- Over the past 5 years, Avadel Pharmaceuticals' Long-Term Debt Repayments peaked at $34.4 million during Q3 2014, and registered a low of -$34.4 million during Q2 2014.
- Over the past 4 years, Avadel Pharmaceuticals' median Long-Term Debt Repayments value was $61000.0 (recorded in 2016), while the average stood at $50909.1.
- Data for Avadel Pharmaceuticals' Long-Term Debt Repayments shows a peak YoY increase of 17214500.0% (in 2014) and a maximum YoY decrease of 18118947.37% (in 2014) over the last 5 years.
- Quarter analysis of 4 years shows Avadel Pharmaceuticals' Long-Term Debt Repayments stood at $223000.0 in 2014, then crashed by 2695.52% to -$5.8 million in 2015, then soared by 101.05% to $61000.0 in 2016, then soared by 604.92% to $430000.0 in 2018.
- Its Long-Term Debt Repayments stands at $430000.0 for Q3 2018, versus $369000.0 for Q2 2018 and $5.4 million for Q1 2018.